English - Ecuador Priority Conditions Packet

Price: $19

An education-only research summary covering ten conditions relevant to Ecuador. They are NOT ranked: no national data on why people in Ecuador use cannabis were found. Six are the uses named in Ecuador's 2021 medical cannabis regulation (Acuerdo Ministerial 00148-2021) and four are regional conditions taken from neighboring Argentina's RACME/CONICET survey, each clearly labeled:

- Refractory epilepsy and spasticity in multiple sclerosis

- Cancer pain, chemotherapy-induced nausea and vomiting, anorexia-cachexia

- Chronic non-cancer pain

- Sleep, anxiety and depression (regional)

- Migraine (regional)

What's inside:

- What published research does and does not show for each condition, with plain evidence-strength labels

- Clinician questions to weigh for every section

- Cautions that apply to all ten: psychosis, cannabis use disorder, hyperemesis, driving, pregnancy, product contents and medicine lists

- Why these ten in Ecuador, and why the list is unranked

- Ecuadorian legal context: COIP Article 220 (2019 reform), Acuerdo Ministerial 00148-2021 including its 1% THC threshold (stated as law only), special prescriptions and pharmacies, ARCSA

- Patient handoff sheets: plain-language one-card summaries a clinician may copy for patients

- 67 numbered sources; every PubMed citation checked by PMID in October 2026

14-page PDF. English edition (the governing version). A Spanish edition is also available.

Education only. No doses, no product recommendations, no drug-interaction verdicts. Not medical or legal advice.

By Annie Romelfanger, Romelfanger Cannabis Education. romelfangercannabis.com